We are live on ! Find out more
ADILW

Adial Pharmaceuticals Warrant
ADILW

Delisted

ADILW was delisted on the 27th of July, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Adial Pharmaceuticals Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $499 → $0 (-$499)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
–
Holders Change
-5
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$200
2
WAM
Wolverine Asset Management
Illinois
-$88
3
GS
GTS Securities
New York
-$86
4
Wells Fargo
Wells Fargo
California
-$86
5
UBS Group
UBS Group
Switzerland
-$39
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
1
Ameriprise
Minnesota
– -$200 -35,000 Closed
WAM
2
Wolverine Asset Management
Illinois
– -$88 -15,606 Closed
Wells Fargo
3
Wells Fargo
California
– -$86 -15,000 Closed
GS
4
GTS Securities
New York
– -$86 -14,401 Closed
UBS Group
5
UBS Group
Switzerland
– -$39 -6,534 Closed

ADILW Hedge Fund Activity: Q3 2023 in Review

0 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q3 2023, worth a combined $0 — down 100% from $499 a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ADILW and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Ameriprise, exiting entirely with an estimated $200 sold.

  • 0 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q3 2023, down from 5 in Q2 2023.
  • Funds reported $0 of Adial Pharmaceuticals Warrant stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Adial Pharmaceuticals Warrant positions in Q3 2023 and 5 closed out, a net change of -5 holders.
  • The largest Adial Pharmaceuticals Warrant seller in Q3 2023 was Ameriprise, an estimated $200 sold.

Based on aggregated 13F filings for Q3 2023.